Rapid HIV Testing for Emergency Department Patients
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Screening
|Official Title:||Rapid HIV Testing for Emergency Department Patients|
- Willingness of participant to have HIV testing [ Time Frame: Throughout study ]
- Participant comprehension of rapid HIV pre-test information [ Time Frame: Throughout study ]
|Study Start Date:||July 2004|
|Study Completion Date:||June 2009|
|Primary Completion Date:||March 2009 (Final data collection date for primary outcome measure)|
Active Comparator: 1
Phase III participants who are educated about risk of HIV infection before receiving a rapid HIV test
Behavioral: HIV risk education
Education for Phase III participants about potential risk of HIV infection before being asked to take a rapid HIV test in the ED
No Intervention: 2
Phase III participants who are not educated about risk of HIV infection before receiving a rapid HIV test
Rapid HIV testing is a new technology that speeds receipt of HIV test results. Its use in EDs has been demonstrated, but patient acceptance of rapid testing in the ED has not been optimal. It is likely that the low acceptance is partially due to ED patients not realizing the risk of acquiring an HIV infection or the importance of knowing their HIV status. The purpose of this study is to test data collection options in EDs and to enhance ED patient awareness of the risk for HIV infection.
This three phase study will take place at the Rhode Island Hospital Emergency Department. Each participant will be followed for the duration of their ED visit.
In Phase I, the proportion of participants who are willing to undergo rapid HIV testing in the ED will be measured. Additionally, the HIV testing history of these participants, their reasons for undergoing testing or for never having been tested for HIV, and factors associated with acceptance or decline of testing and history of HIV testing will be determined. An educational video will be developed and used to investigate its effectiveness in convincing participants to have the rapid HIV test. All participants agreeing to undergo a rapid HIV test will receive a survey to complete.
In Phase II, a questionnaire and feedback tool to make participants aware of their risk for an HIV infection through injection drug use and sex will be developed and investigated.
In Phase III, the questionnaire and feedback tool developed in Phase II will be used to determine whether or not making participants aware of their risk for an HIV infection increases their acceptance of being tested for HIV in the ED. Participants in Arm 1 will receive the questionnaire and feedback tool while participants in Arm 2 will not.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00676481
|United States, Rhode Island|
|Rhode Island Hospital Emergency Department|
|Providence, Rhode Island, United States, 02903|
|Principal Investigator:||Roland C Merchant, MD, MPH, ScD||Rhode Island Hospital/Warren Alpert Medical School|